TrialGrid Limited Releases First Integrated Study-Build Environment Designed Exclusively to Assist Users of Medidata Rave

News provided by

TrialGrid Limited

Oct 16, 2017, 03:00 ET

London, UK (PRWEB) October 16, 2017 -- TrialGrid is the only integrated environment designed exclusively to assist users of the market-leading EDC solution, Medidata Rave, improve the efficiency and quality of their study builds:

  • Study Build Diagnostics highlight potential build issues and encourage conformance to best practices
  • Standards Compliance workflow improves adherence to company standards and simplifies the process to manage and reduce deviations from standards
  • Edit Checks and other study objects can be quickly created, copied and tested, reducing the time to complete the study build
  • Changes to the study are automatically tracked in an audit trail

“After one year of development and positive feedback from our beta test users, we’re delighted to complete the first production-ready release of the TrialGrid application” said Andrew Newbigging, TrialGrid’s CEO. “We now have two top 15 pharmaceutical companies, two top 10 global CROs and leading academic research institutes piloting the use of TrialGrid.”

Steve Heath, TrialGrid’s Chief Commercial Officer declared, “Delays in building and releasing clinical study databases are a perennial concern, as highlighted in the recent Tufts eClinical landscape. TrialGrid is designed to reduce the initial time and effort in building studies for Medidata Rave by up to 50% and reduce the risk of errors in the build requiring correction after go-live.”

Commenting on future plans, Ian Sparks, CTO, said “We will continue to improve and expand the functionality of TrialGrid, adding specification management, automated user acceptance testing and annotated pdfs over the coming months. Our vision is for all activities associated with building a Medidata Rave study to be managed in one environment, eliminating the need for additional spreadsheets and other documents.”

For further information:

Andrew Newbigging, TrialGrid Limited, http://www.trialgrid.com, +44 7712 536084, [email protected]